What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

My Stock Value Strategy Starts Now (4 Viewers)

Once my Option account gets approved, I am looking to bet heavily on UNG via something like this:

http://finance.yahoo.com/q?s=UNYJI.X

This would lock in an easy strike price of $9.00 (it's trading at nearly $14 now and I can't see a scenario where UNG goes that low). At $5.30, it would allow me to accumulate nearly 3X my normal stocks. Also looking to do this with Aluminum (CENX)

 
Does anyone have thoughtson REITS? I have been researching them and can't see much downside (I believe the real estate market can't go much lower). A lot of them have high dividends compared to current cost (25%). They also stand to increase stock price as most are a fraction of historical prices.One that I have an eye on is RAS. It is a bit different because it invests in mortgages and loans, and therefore has high risk and volitility. But it is currently 1/25th of last years price and is returning 100% in dividends. It is a gamble to be alive in a year, but if it is, you would see a good profit.Any REIT people?
You need to do some more research.You don't see much downside? Well, there is quite a bit of downside. Look at General Growth Properties, which was one of the strongest REIT's around. The downside is tons of people/businesses are defaulting/declaring bankruptcy, etc.... On the commercial side, occupancy rates are very low, and this is not very good. These "dividends" are not guaranteed, rather a payout of operating income, which is quickly evaporating. There is a reason that most REIT's are trading at these low levels.I have owned a lot of REIT's in the past. I have not owned one in over 3 years now and would not be looking to get back in anytime soon.I don't know much about RAS, so I can't answer on that one specifically. The dividend you listed above is sure to get cut/eliminated though. You can't look at historic dividends and expect these in the future with REIT's.just my opinion.
 
HEB has to be down way more than that to be considered "down bad".

Re: reits. We've been in and out of BEE. But we've usually been getting in at about a buck and out at 1.50 and its currently above that that's about all I've studied on that

 
Very Good Natural Gas articles...

article

and aother
The first article was fantastic, but this quote from the second one sas it all to me.A sharp contango encourages investors and producers to store natural gas and wait for a higher price in the winter, which could further dampen spot prices and make the contango even steeper.

The current contango in natural gas is reminiscent of the "super contango" in crude-oil futures that occurred about half a year ago. At that time, crude contango helped push inventories at Cushing, Okla., the delivery point for Nymex crude futures, to a record high. See related story.

Crude has since rallied more than 50%, while Cushing inventories have slumped 14% from their peak.

 
Rimm got a nice upgrade by goldman. One of the few analysts i will consider following(not blindly, always do a little research). Upped the target price to 96.

BTW, could this 10-15 % market correction every experts predicting actually be this flatline phase we are in? Me, i'm a bull in nature and predict that the dow will be at 10k by end of yr. In the end, i might be a little on the conservative side with this. The old adage of sell in may and go away seems to be ringing true, at least thus far.

 
VIAP looks to be the biopharm to explode this morning. Not sure if this is a pump & dump (found out about it on a different yahoo message board) or if the news is worthy. If you can get in low this morning you may be able to take it for a nice ride. News is they met with the FDA to review transition from Phase 2 to Phase 3. It’s always tough to predict these, but I would expect at least a pop today, who knows if it will sell off by EOD or keep running like AGEN did…..

LOL bid .75 ask 999.99

 
I am watching CENX at level 2 and this one is in play I think....rocketship
I'll take a shot here along with you. Put a lowball number out there and see if it hits. 4 september 2.50 calls with my lowball 4.50 premium offer. Bids are 4.90 and asks are 5.00. With the market jump from +40 to +80 just now, probably won't get filled.
 
Bought 6,705 SPNG at avg cost .19. Very interesting company. Check out this post from the yahoo board. Dude seems like he knows what’s up. Who knows, he could be full of it and I’ll lose all my money in a pump and dump scam.

http://messages.finance.yahoo.com/Stocks_%...mp;frt=1#116479

Updated SPNG Primer 10-Jun-09 01:30 pm

In light of the Noble investor conference and the tremendous response to my first primer, I have produced an updated version:

SPNG is a two-part investment -- the fundamentals and the (potential) squeeze.

FUNDAMENTALS:

1. They sell high-tech sponges. Until fairly recently, they have mostly been selling the auto sponge, but they have a pet sponge and a Spongebob kid bath sponge. They have also just yesterday begun shipping their anti-microbial sponge targeting the cleaning needs associated with swine flu. They are developing kitchen/bath cleaning sponges and have confirmed that they have done focus group work with Reckitt Benckiser (Lysol) regarding a Lysol/Spongetech branded product – and at the June 8 Noble investor conference (Noble) they indicated that they are in late stage negotiations with the “biggest” name in this business (and Lysol is the #1 surface disinfectant). They have also mentioned a sunscreen sponge and some pharma applications. They have also signed deals for the kid sponges with Viacom to do Dora and Go Diego, as well as with MGM (Pink Panther, which is going to be polished up and re-released). There are rumors of other kid character sponges.

2. They have had huge success penetrating domestic mass retail (Costco, CVS, Walgreens, Jewel/Osco, Duane Reade, ACE, Krogers, Price Chopper, etc). They are advertised on Howard Stern and a ton of sports venues. The pet sponge is in Petco and Petsmart. The auto sponge also sells overseas, including Walmart South America. And at Noble we saw Walmart listed for the first time as a retail. In the past, Metter (CEO) has given as a target trying to get SPNG into 100,000 retail “doors”. At Noble he stated it as a fact that by the end of this summer they would achieve that goal! (Just imagine if they could net $0.50 per day per retail store. That would be $18mm in earnings per year... This is just an interesting back of the envelope calculation. See the more detailed discussion below.)

3. They are growing at a very rapid pace. Revs for all of fiscal 2008 (which ended May 31, 08) were 5.6mm. They just announced prelimary numbers for fiscal 2009 that were nearly 10 times higher (“over $50mm”). Recent recent orders plus the Spongebob sponge’s potential suggests we are on a pace to do over $200mm in fiscal 2010 (which started June 1).

4.a. Net margins have declined from 20 percent to 11 percent in the most recent quarterly filing (Q3 09, ended 28 Feb). A big chunk of the decline is that they now pay taxes. Also, they appear to have experienced some natural margin compression in the process of accessing mass retail. On the other hand, advertising as a percentage of revenue is going down (basically, ad spending, while large, is not rising as fast as revenues).

4.b. Earnings growth has been solid. Based on the preliminary numbers (and allowing for taxes at the same rate paid in Q3 09), the Q4 net (after-tax) income was $2.51mm. This is $0.00348 per share (using the 4/16 OS of 722mm) – or annualizing (mult by 4) gives about 1.4 cents of EPS (or more if OS comes down and earnings grow).

Here’s the quarter by quarter net after-tax income. In looking at this, note that the dip down in Q3 09 is because they started having to pay taxes. The pre-tax numbers grow more evenly:

Q2 08 $8,668

Q3 08 $188,482

Q4 08 $1,055,973

Q1 09 $1,076,053

Q2 09 $2,320,985

Q3 09 $1,513,422

Q4 09 $2,508,351

5. They are doing a great job collecting their receivables. For me, the key is to compare A/R to quarterly revenues. This has been relatively stable. This is important -- they had 14mm of A/R on the books. If they weren't collect it, that would obviously be a huge red flag. Well, the ratio (A/R)/Rev in the past several quarters was: 0.78, 0.91, 0.64, 0.88, 1.06.

6. When looking at the balance sheet, take care to understand the advertising pre-pays and pre-paid production. They have to put cash out the door to get advertising and to get sponges to sell. For some reason, this has mystified some posters. Yes, it is a drain on cash, but it lowers cash outlays in the future. Not rocket science, but perhaps easy to miss.

7. All of this growth requires capital. Where do they get financing? They get it by selling shares to RME, a company controlled by management. These guys have a lot of money (Carter's clothes is a family biz). So, no need for the classic toxic financing. They have issued a ton of shares to RME since Jan 08, but here's the kicker: RME HAS GIVEN SPNG THE OPTION TO BUY BACK A LARGE CHUNK OF THE SHARES AT THE ISSUE PRICE AT ANY TIME UNTIL SPRING OF 2010. DO YOURSELF A FAVOR AND MODEL THIS TWO WAYS -- once with the full number of shares (722mm as of 4/16) and again with the 480mm RME shares treated like a loan. Indeed, most of the RME shares are DOUBLY RESTRICTED. They are unregistered and they are covered by the option grants (so that selling would put them in the position of having issued uncovered calls). The RME options are in 2 parts. The first is in the July 2008 8K. The second (for the more recently-issued shares) has been discussed in a PR, but we have not seen this in an SEC filing.

8. Can we expect further share reductions? Well, back when I first got involved with SPNG, they were saying they wanted to eventually get the O/S down to 100mm. Now I think they are targeting a number maybe twice that. But perhaps more important if you are making an investment is what they have stated in their SEC-filed docs. In Q3 09, they said that they had an additional 133mm RM shares that they would retire (bringing OS down from 722mm to 589mm. Plus, they have at least 55mm (and I would guess closer to 100mm now) share to retire from the buyback from the float. Thus, I think a reasonable near term target would be somewhere around 500mm. IF they can get rid of most or all of the RM shares and get OS down to 250mm or lower, then that would be unreal.

9. If all 2B authorized shares are out there and not being bought back, then we would have revs of 200M in 2010, earnings of 20M, and EPS of 1 penny per share. At 722, we are at about 3 cents EPS. IF the RME shares disappear and/or they buy back more to get to management's target of 200mm, then EPS would be 10 cents. If they attain this lower OS, then we would be looking at fundamentals that support a price over 50 cents on a very conservative P/E of 5 (or a share price of $1 on a P/E of 10). So, there is considerable value here, even if we never see a squeeze...

THE SQUEEZE

9. I am deeply skeptical when folks complain about colluding market makers and evil naked shorters. But in this instance there might indeed be a VERY large short position that does not show up on the official short interest stats. The story I have seen posted is that shorts sold a ton of shares back in 07 or early 08 and then approached management. They said they would go away if management sold them the covering shares at a low price. Management did not want to dilute the float in this way, so they told them to f*** off. This short position has grown over time – and now management is in a position to move decisively.

10. What is the evidence of a short position? Well, as of 4/16 we had just over 200mm tradable shares (722mm O/S – 480mm RM – 25mm officer shares on 08 10k = about 200mm). Doug Furth is reputed to own that many or more -- and he has filed a 13G for a fund he runs (41mm in the filing). There is a second 13G of 40mm (some members of that 13G have sold, but others have bought more. S Moskowitz (COO) is reputed to own a ton as well. He reputedly used BMAS -- a market maker that ALWAYS appears on the bid, never on the ask. (Note that management does NOT need to report these, because they file as a 1933 Act company -- their assets fall below the 1934 Act threshold.) Remember that SPNG was trading at $0.006 not all that long ago. At that price, an additional 100mm shares would have only cost SM $600k. Then there have been various investor polls that routinely come up with more ownership than the tradable. The DrStock post that is often bumped discusses a group holding 170mm shares among a relatively small group of investors. I personally know of over 20mm other shares by folks not in that group. And there were 7000 shareholders as of a month ago (probably more now). Try to fit all of that into 200mm tradable shares! And try to explain the volume, when so many of the shares are in strong hands! Really, I defy you to explain this to me without there being a short of AT LEAST 400mm.

11. Can the shorts cover? This is a very interesting question! I strongly suspect that tightly held large positions by insiders and Doug Furth and possibly some of our recent buyers HAVE **EACH** ####### CORNERED THE SHORTS. That means that the shorts would have to buy all of the shares held by retail longs and they'd STILL BE SHORT until they knock on Doug Furth’s door and ask him what he wants them to pay. And even then they would STILL BE SHORT until they knock on Steven Moskowitz's door and find out what he is asking. Shades of VW and Porsche – except that Porsche had to back off once it became clear that the entire German financial system was at risk. SPNG could be a larger squeeze in percentage terms. And remember – the shorts tried to destroy SPNG over the past 18 months. This payback has been a long time coming, but what is they say about revenge being a meal best served cold?

12. So what will bring the shorts to the table? What will make them cover? Back when I posted an earlier version of this in December 08, I wrote that the most likely scenario would be "the company reverse merges into a shell company. Or perhaps a dividend or CUSIP change. Or, maybe they get taken private." Hmmmmm. Did anyone notice a PR just a while ago about applying to uplist to Nasdaq? A reverse merger into Nasdaq requires the controlling company to file an application for listing and the company must meet all requirements EXCEPT FOR PRICE... I have no idea what is going to happen, but I think one has to consider it a strong possibility that SPNG is going to do a reverse merger with a small Nasdaq company, which would force the shorts to cover.

This is all in my honest opinion. I could not presume to advise anyone what they should do! I have made a very major commitment of $$ to this stock - 4.75M shares at 2.4 cents average. I have not sold any shares yet. But you should do your own DD. Call up management if you are thinking of making a serious investment. Don't bother them with calls about 50K shares, but they will spend a lot of time with you regardless of the size of your position. Bill Young (IR) is a good place to start, but the real deal is Moskowitz. IF you have trouble getting through, then take that as a good thing. It may be that they are not talking because of the Nasdaq stuff. (FWIW, I have never spoken with Metter, and the emails I've received from him were rather offensive (mine to him might have been a tad over the line as well -- LOL).

In previous installments, I used to say that I would NOT buy SPNG based on the potential for a squeeze – but rather to focus on the fundamentals. Well, now we are at 16 cents, and while I see fair value being much higher, getting to fair value would *only* (LOL) be a double or quadruple from here. At the same time, I am becoming a stronger and stronger believer in the squeeze. So, now I rate this as a very strong buy based on the fundamentals -- and a table pounder based on the squeeze.

How rare is it that you have BOTH a fundamentals play and a squeeze play on the same stock?

Wadi Rum

 
Oh My.....60,000 shares of CENX disappeared at 7.60 in a flash on level 2. Rocketship baby

 
Last edited by a moderator:
Speaking of HEB, does anyone know how we will know if Ampligen isn't approved? Will the FDA announce an unapproval? :unsure:
Anyone?Lots of FBG $ going into this and I'm not sure we'd know if approval's already been denied?
Unknown, but I'm sticking around. My gut is telling me they would of denied it by now if they were going to.Sitting on 2000 shares @ $2.78. Now have a buy order set for 300 more shares at a 5% trailing stop.I also wrote some code that will check the FDA new drugs site, HEB investors site, and NASDAQ "trading halt" web site and will notify me when some news is released.
 
Last edited by a moderator:
My thoughts regarding HEB. I think upside on this stock via approval is in the $8-9 range. So even if they get something less than full approval, this price seems fair. I think the downside on this stock with a bad rejection is around $0.70. Since 90% of drugs that are in phase 3 get approved, doesn't this bet at these prices make sense? I know it's either going to be approved or not, but I have to think that every day there is no answer, this is closer to a yes. Why wait to say no?

 
Oh My.....60,000 shares of CENX disappeared at 7.60 in a flash on level 2. Rocketship baby
Thanks DD. Got in CENX (4000 shares) yesterday. Quite happy! Also UNG 1000 shares.Liked your logic on both and also how charts looked.Figured would hold these for a while as "safe" upside investments. :hifive:
 
Oh My.....60,000 shares of CENX disappeared at 7.60 in a flash on level 2. Rocketship baby
Thanks DD. Got in CENX (4000 shares) yesterday. Quite happy! Also UNG 1000 shares.Liked your logic on both and also how charts looked.Figured would hold these for a while as "safe" upside investments. :goodposting:
I generally hate buying and holding but liking these here. I think they are safe against a market correction too which could hit soon.
 
My thoughts regarding HEB. I think upside on this stock via approval is in the $8-9 range. So even if they get something less than full approval, this price seems fair. I think the downside on this stock with a bad rejection is around $0.70. Since 90% of drugs that are in phase 3 get approved, doesn't this bet at these prices make sense? I know it's either going to be approved or not, but I have to think that every day there is no answer, this is closer to a yes. Why wait to say no?
Been waiting for the WHO stage 6 announcement to bump this a bit today to jump on the ride up. In for 1000 at 2.28 again. gllllllllllllllll peas
 
Im off to vegas for the WSOP. Ill be the one wearing the "PRGN paid for this" t-shirt.

Hopefully UNG is $16 when I get home Monday.

 
PRGN has been on a hard slide since they put out the news on the "other" 10m shares... off over 15% since then. Glad most of you got out... me, notsomuch.

 
This is where I need some help/advice.

I wanted to enter into UNG carefully so I only bought into 400 shares. Now we have a large bump in one afternoon. Do I dollar cost up from here to build the posistion to get to the 1000 shares that I wanted? Or do I just hold what I have already for the rest of the ride?

 

Users who are viewing this thread

Back
Top